These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11566494)

  • 21. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ketamine/xylazine on expression of tumor necrosis factor-alpha, inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa during endotoxemia.
    Helmer KS; Cui Y; Chang L; Dewan A; Mercer DW
    Shock; 2003 Jul; 20(1):63-9. PubMed ID: 12813371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of COX-2 in stomach cancers and its relation to their biological features.
    Han SL; Tang HJ; Hua YW; Ji SQ; Lin DX
    Dig Surg; 2003; 20(2):107-14. PubMed ID: 12686777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.
    Soo R; Putti T; Tao Q; Goh BC; Lee KH; Kwok-Seng L; Tan L; Hsieh WS
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):147-52. PubMed ID: 15723947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).
    Chiarugi V; Magnelli L; Gallo O
    Int J Mol Med; 1998 Dec; 2(6):715-9. PubMed ID: 9850741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
    Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
    Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
    Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
    Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus.
    Ribeiro M; Cella M; Farina M; Franchi A
    Neuroimmunomodulation; 2004; 11(3):191-8. PubMed ID: 15067210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase 2, p53, beta-catenin, and APC protein expression in gastric adenomatous polyps.
    Smith GV; Feakins R; Farthing MJ; Ballinger A
    Am J Clin Pathol; 2005 Mar; 123(3):415-20. PubMed ID: 15716238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer.
    Joo YE; Chung IJ; Park YK; Koh YS; Lee JH; Park CH; Lee WS; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    J Korean Med Sci; 2006 Oct; 21(5):871-6. PubMed ID: 17043422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer.
    Bing RJ; Miyataka M; Rich KA; Hanson N; Wang X; Slosser HD; Shi SR
    Clin Cancer Res; 2001 Nov; 7(11):3385-92. PubMed ID: 11705852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between inducible nitric oxide synthase expression and p53 status in human esophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Kurabayashi A; Araki K; Sasaguri S; Ohtsuki Y
    Oncology; 2003; 64(1):90-6. PubMed ID: 12457036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer.
    Wang L; Shi GG; Yao JC; Gong W; Wei D; Wu TT; Ajani JA; Huang S; Xie K
    Gastric Cancer; 2005; 8(1):18-28. PubMed ID: 15747170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.
    Leung WK; To KF; Ng YP; Lee TL; Lau JY; Chan FK; Ng EK; Chung SC; Sung JJ
    Br J Cancer; 2001 Feb; 84(3):335-9. PubMed ID: 11161397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?
    Ugraş N; Özgün G; Ocakoğlu G; Yerci Ö; Öztürk E
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():176-81. PubMed ID: 25910300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma.
    Chen XL; Su BS; Sun RQ; Zhang J; Wang YL
    World J Gastroenterol; 2005 Feb; 11(8):1228-31. PubMed ID: 15754411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.